NCT07310784 2026-03-03
A Phase II Trial of LM103 in Advanced Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase 2 Recruiting
Clinical Trials
6 trialsNCT05869539 2026-02-27
BaseTIL-03M
University Hospital, Basel, Switzerland
Phase 1 Active not recruiting
NCT05098184 2025-12-11
A Study of GC101 TIL in Advanced Melanoma (10hospital)
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT07107178 2025-08-06
A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma
Biotroy Therapeutics
Phase 1 Not yet recruiting
NCT03407170 2020-07-15
KEYNOTE-161
Merck Sharp & Dohme LLC
Phase 2 Terminated
NCT03818893 2019-01-30
Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII
Osaka University
Phase 2 Unknown